List of Contents

Veterinary Pharmacovigilance Market Size, Share, and Trends 2024 to 2034

The global veterinary pharmacovigilance market size accounted for USD 986.84 million in 2024, grew to USD 1,109.21 million in 2025 and is projected to surpass around USD 3,176.21 million by 2034, representing a healthy CAGR of 12.40% between 2024 and 2034. The North America veterinary pharmacovigilance market size is worth around USD 414.47 million in 2024 and is expected to grow at a fastest CAGR of 12.53% during the forecast period.

  • Last Updated : October 2024
  • Report Code : 3331
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Veterinary Pharmacovigilance Market 

5.1. COVID-19 Landscape: Veterinary Pharmacovigilance Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Veterinary Pharmacovigilance Market, By Solution

8.1. Veterinary Pharmacovigilance Market Revenue and Volume Forecast, by Solution, 2024-2034

8.1.1. Software

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Services

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Veterinary Pharmacovigilance Market, By Product

9.1. Veterinary Pharmacovigilance Market Revenue and Volume Forecast, By Product, 2024-2034

9.1.1. Biologics

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Anti-infectives

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Veterinary Pharmacovigilance Market, By Type 

10.1. Veterinary Pharmacovigilance Market Revenue and Volume Forecast, by Type, 2024-2034

10.1.1. In-house

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Contract Outsourcing

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Veterinary Pharmacovigilance Market, By Animal Type 

11.1. Veterinary Pharmacovigilance Market Revenue and Volume Forecast, by Animal Type, 2024-2034

11.1.1. Dogs

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Cats

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Veterinary Pharmacovigilance Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.1.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.2.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.3.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Solution (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

Chapter 13. Company Profiles

13.1. Zoetis Inc.

13.1.1. Company Overview

13.1.2. Type Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Merck & Co., Inc. (Merck Animal Health)

13.2.1. Company Overview

13.2.2. Type Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Boehringer Ingelheim Animal Health

13.3.1. Company Overview

13.3.2. Type Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Elanco Animal Health

13.4.1. Company Overview

13.4.2. Type Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Virbac

13.5.1. Company Overview

13.5.2. Type Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bayer Animal Health

13.6.1. Company Overview

13.6.2. Type Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Ceva Santé Animale

13.7.1. Company Overview

13.7.2. Type Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Vetoquinol

13.8.1. Company Overview

13.8.2. Type Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. IDEXX Laboratories, Inc.

13.9.1. Company Overview

13.9.2. Type Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Covetrus

13.10.1. Company Overview

13.10.2. Type Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us